Elsevier

The Lancet

Volume 344, Issue 8921, 20 August 1994, Pages 502-507
The Lancet

Articles
Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls

https://doi.org/10.1016/S0140-6736(94)91897-XGet rights and content

Abstract

Summary

To assess the efficacy of liver transplantation in patients with alcoholic cirrhosis, we compared 2-year survival of 169 liver transplantation patients in 12 French centres with survival of two control groups treated conservatively.

The matched group was 169 patients of similar age, cirrhosis severity, and bleeding history; the simulated group was 169 patients whose theoretical survival was determined in a cohort of 797 patients with alcoholic cirrhosis. The probability of survival to 2 years in transplanted patients was 73 (95% confidence interval 67-79%) versus 67% (59-75) in the matched and 67% (63-71) in simulated controls. When prognostic factors were taken into account, transplantation was associated with survival (r=0·527; p=0·069). Patients with severe liver disease (high-risk group) benefited most for 2-year survival: 64% (42-86) vs 41% (23-59) in the matched and 23% (19-27) in the simulated control groups (p<0·01). There was no difference for patients at low and at medium risk. Liver transplantation increases the 2-year survival of patients with severe alcoholic cirrhosis. In patients with less severe disease, further studies should be done by non-randomised controlled studies with longer follow-up or by randomised trials.

References (17)

  • Mf Sorrell et al.

    Transplantation in the alcoholic: a stalking horse for a larger problem

    Gastroenterology

    (1992)
  • T. Poynard et al.

    A simple biological index for detection of alcoholic liver disease in drinkers

    Gastroenterology

    (1991)
  • S. Kumar et al.

    Orthotopic liver transplantation for alcoholic liver disease

    Hepatology

    (1990)
  • S. Shenker et al.

    Should patients with end-stage alcoholic liver disease have a new liver?

    Hepatology

    (1990)
  • M. Doffoel et al.

    Résultats et indications de la transplantation hépatique dans la cirrhose alcoolique

    Gastroenterol Clin Biol

    (1991)
  • Bh Markus et al.

    Efficacy of liver transplantation in patients with primary biliary cirrhosis

    N Engl J Med

    (1989)
  • Er Dickson et al.

    Prognosis in primary biliary cirrhosis: model for decision making

    Hepatology

    (1989)
  • T. Poynard et al.

    Prognostic value of total serum bilirubin/gamma-glutamyl transpeptidase ratio in cirrhotic patients

    Hepatology

    (1984)
There are more references available in the full text version of this article.

Cited by (85)

  • Liver transplantation in patients with alcohol-related liver disease: current status and future directions

    2020, The Lancet Gastroenterology and Hepatology
    Citation Excerpt :

    The survival of patients with alcohol-related liver disease who receive a liver transplant has steadily improved to reach 80–85% at 1 year post-transplantation.1 However, liver transplantation should not be offered to patients with alcohol-related liver disease who have moderately impaired liver function, since modelling studies have not shown a survival benefit of transplantation versus no transplantation in patients with intermediate disease severity.2–4 Similar to other indications for liver transplantation, the MELD prognostic score is used to prioritise organ allocation for candidates with alcohol-related liver disease.5

  • Alcoholic Liver Disease

    2012, Zakim and Boyer's Hepatology
  • Alcohol and the liver

    2009, Gastroenterologie Clinique et Biologique
View all citing articles on Scopus
1

Members are listed at the end of the report

View full text